Clinical trial
Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation…
NCT00255190 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00255190 |
|---|---|
| Title | Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn |
| Official title | A Phase 3, Open-Label Study to Assess the Long-Term Safety of Dexlansoprazole MR (60 mg QD and 90 mg QD) |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastroesophageal Reflux Disease |
| Intervention type | Drug |
| Interventions | Dexlansoprazole MR |
| Enrollment | 591 |
| Start date | Jan 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Nov 17, 2005 |
| Last update posted | Jul 27, 2016 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: